Yang; Sai
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yang; Sai.The latest application filed is for "endocyclic thiamidinoamide-arylamide compound and use thereof for treating hepatitis b".
- Yang; Sai - Shanghai CN
- Yang; Sai - Beijing CN
| Patent | Date |
|---|---|
| Endocyclic thiamidinoamide-arylamide compound and use thereof for treating hepatitis B Grant 11,168,055 - Wang , et al. November 9, 2 | 2021-11-09 |
| Endocyclic Thiamidinoamide-arylamide Compound And Use Thereof For Treating Hepatitis B App 20200399216 - WANG; Zhe ; et al. | 2020-12-24 |
| Bicyclic Nucleocapsid Inhibitor And Use Of Same As Drug In Treatment Of Hepatitis B App 20200354366 - WANG; Zhe ; et al. | 2020-11-12 |
| Jak Kinase Inhibitor And Preparation Method And Use Thereof App 20190382408 - WANG; Zhe ; et al. | 2019-12-19 |
| Auto login method and device Grant 9,584,504 - Wan , et al. February 28, 2 | 2017-02-28 |
| Auto Login Method And Device App 20140344907 - Wan; Yong ; et al. | 2014-11-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 